Baylink Biosciences is focused on developing innovative antibody-drug conjugates (ADCs) for cancer treatment. Baylink has created a panel of linker-payloads that enhance the delivery of hydrophobic compounds with high drug-to-antibody ratios (DAR) and stability. Baylink is advancing several product candidates based on this platform to the clinic that represent first-in-class or best-in-class ADC therapeutics.
Company Details
- Employees
- 7
- Founded
- 2024
- Address
- 2460 Embarcadero Way,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.baylinkbio.com
- Keywords
- Antibody drug conjugates.
- HQ
- Palo Alto, California
Baylink Biosciences Questions
Baylink Biosciences's website is http://www.baylinkbio.com
Baylink Biosciences's LinkedIn profile is https://www.linkedin.com/company/baylink-biosciences
Baylink Biosciences has
7 employees.
View email and phone details for 7
employees at Baylink Biosciences.
Baylink Biosciences's industry is
Biotechnology Research
Baylink Biosciences's top competitors are
Staidson Biopharma Inc,
Aeterna Therapeutics,
Tailored Therapeutics,
Onconox Inc.,
Takura Ab,
Staidson (Beijing) Biopharmaceuticals Co., Ltd,
Anteris,
Asieris Pharmaceuticals,
3dam2025 Conference,
Curacell.
Baylink Biosciences's categories are Biotechnology Research
Baylink Biosciences's founding year is 2024
